Rizvi Syed Ali-aamir bought RCKT
October 6, 2025 · Form 4 insider transaction
Rizvi Syed Ali-aamir bought 383,854 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
383,854
Price
$0.00
Total value
N/A
InsiderRizvi Syed Ali-aamir
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 6, 2025
Filing dateOctober 8, 2025
Shares owned after383,854
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents non-qualified stock options ("NQSOs") that convert to common stock on a one-for-one basis. One-third (1/3) of such NQSOs will become fully vested on October 6, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.